New research is exploring low-cost, non-invasive ways to diagnose Barrett's esophagus, a condition associated with deadly esophageal cancer, to find effective strategies to identify patients with this condition.
Oct 28, 2024
0
0
A man from Cambridge is the first to join the surveillance part of a clinical trial that could see routine screening for esophageal cancer introduced into the NHS, potentially halving deaths from this cancer every year.
Jan 10, 2024
0
3
A 67-year old patient presenting with esophageal cancer has been treated at the Paul Scherrer Institute PSI with a form of radiation provided by protons, i.e., positively charged particles. This is the first time this type ...
Aug 16, 2023
0
4
Researchers at Oxford University's Nuffield Department of Primary Care Health Sciences have developed a new tool to predict people's risks of getting esophageal cancer in the next ten years.
Aug 15, 2023
0
2
A protective mutation found in most cells in the human esophagus reduces tumor growth in mice, potentially highlighting new ways to prevent or treat cancer in similar tissues.
Jan 20, 2023
0
55
A group of drugs commonly used to treat erectile dysfunction may be able to boost the effect of chemotherapy in esophageal cancer, according to new research.
Jun 21, 2022
0
137
'Prehab' exercise may boost the impact of chemotherapy given to patients with cancer of the food pipe (oesophagus) to shrink their tumour (s) before surgery, reveals the first study of its kind, published online in the British ...
Feb 1, 2022
0
8
Cells carrying mutations can out compete early tumors in the mouse esophagus, so they never make it into cancers, new research has shown.
Oct 13, 2021
0
23
Abnormal cells that go on develop into oesophageal cancer—cancer that affects the tube connecting the mouth and stomach—start life as cells of the stomach, according to scientists at the University of Cambridge.
Aug 12, 2021
0
58
Cancer Research UK-funded researchers have developed a new technique to help experts diagnose Barrett's esophagus—a pre-cancerous condition that can increase the risk of developing oesophageal cancer.
Apr 16, 2021
0
71
Esophageal cancer (or oesophageal cancer) is malignancy of the esophagus. There are various subtypes, primarily squamous cell cancer (approx 90-95% of all esophageal cancer worldwide) and adenocarcinoma (approx. 50-80% of all esophageal cancer in the United States). Squamous cell cancer arises from the cells that line the upper part of the esophagus. Adenocarcinoma arises from glandular cells that are present at the junction of the esophagus and stomach.
Esophageal tumors usually lead to dysphagia (difficulty swallowing), pain and other symptoms, and are diagnosed with biopsy. Small and localized tumors are treated surgically with curative intent. Larger tumors tend not to be operable and hence are treated with palliative care; their growth can still be delayed with chemotherapy, radiotherapy or a combination of the two. In some cases chemo- and radiotherapy can render these larger tumors operable. Prognosis depends on the extent of the disease and other medical problems, but is fairly poor.
This text uses material from Wikipedia licensed under CC BY-SA
